Company: RGBP
Filing Date: 2025-08-11
Form Type: 10-Q
Source: 0001641172-25-022884
Chunk: 12

Company: Regen BioPharma Inc
Filing Date: 2025-08-11
Form: 10-Q
Item: Part I, Item 1
Chunk 12
---
 the Company, whether such assets are capital, surplus or
earnings, an amount equal to $0.01 per share of Series A Preferred (the “ Liquidation Amount”) plus all declared and unpaid
dividends thereon, for each share of Series A Preferred held by them.

If,
upon any Liquidation, the assets of the Company shall be insufficient to pay the Liquidation Amount, together with declared and unpaid
dividends thereon, in full to all holders of Series A Preferred, then the entire net assets of the Company shall be distributed among
the holders of the Series A Preferred, ratably in proportion to the full amounts to which they would otherwise be respectively entitled
and such distributions may be made in cash or in property taken at its fair value (as determined in good faith by the Board), or both,
at the election of the Board.

On
January 10, 2017 Regen Biopharma, Inc. (“ Regen”) filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”)
with the Nevada Secretary of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock
designated and known as “ Series M Preferred Stock” (hereinafter referred to as “ Series M Preferred Stock”).

The
Board of Directors of Regen have authorized 60,000,000 0.0001

The
holders of Series M Preferred Stock shall be entitled receive dividends, when, as and if declared by the Board of Directors in accordance
with Nevada Law, in its discretion, from funds legally available therefore

On
any voluntary or involuntary liquidation, dissolution or winding up of Regen, the holders of the Series M Preferred Stock shall receive,
out of assets legally available for distribution to Regen’s stockholders, a ratable share in the assets of Regen.

On
March 26, 2021 Regen Biopharma, Inc. (“ Regen”) filed a CERTIFICATE OF DESIGNATION (“ Certificate of Designations”)
with the Nevada Secretary of State setting forth the preferences rights and limitations of a newly authorized series of preferred stock
designated and known as Nonconvertible Series NC Preferred Stock (hereinafter referred to as “ Series NC Preferred Stock”).

The
Board of Directors of Regen have authorized 20,000 0.0001

The
holders of Series NC Preferred Stock shall be entitled receive dividends, when, as and if declared by the Board of Directors in accordance
with Nevada Law,